Press releases

23
Jun 2017
16:47 E.S.T.

Calyxt Files Registration Statement for Proposed Initial Public Offering

Read more
9
Jun 2017
20:30 E.S.T.

Annual General Meeting of June 26, 2017

Read more
10
May 2017
20:30 E.S.T.

Cellectis Patent Encompassing Broad Uses of Gene Editing Technologies Maintained by USPTO

Read more
9
May 2017
20:30 E.S.T.

Cellectis Reports 1st Quarter 2017 Financial Results

Read more
27
Apr 2017
20:30 E.S.T.

Cellectis CEO Selected as Speaker for 2017 Milken Institute Global Conference

Read more
25
Apr 2017
20:30 E.S.T.

Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting

Read more
12
Apr 2017
20:30 E.S.T.

Cellectis S.A. to Explore Possible Initial Public Offering of Calyxt, Inc.

Read more
31
Mar 2017
20:30 E.S.T.

Cellectis to Present at the 2017 Annual Conference of the American Association for Cancer Research

Read more
9
Mar 2017
21:30 E.S.T.

Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia

Read more
7
Mar 2017
21:30 E.S.T.

Five Additional Leading Physicians to Join Cellectis Clinical Advisory Board

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US